Lovick Edward Cannon
Chief Executive Officer at Unigen Pharmaceuticals, Inc.
Profile
Lovick Edward Cannon is the founder of Dyax Corp.
which was founded in 1995.
He is also the founder of Hygeia Sciences, Inc. Dr. Cannon's current jobs include President & Chief Executive Officer at Unigen Pharmaceuticals, Inc., President, Chief Executive Officer & Director at NovAb, Inc., and Director at Akston Biosciences Corp.
Dr. Cannon's former jobs include President & Chief Executive Officer at AdipoGenix, Inc. from 2004 to 2011, President & Chief Executive Officer at Elixir Pharmaceuticals, Inc. from 2001 to 2004, Chief Executive Officer & Director at Protein Engineering Corp, and Director at SmartCells, Inc. from 2000 to 2012.
Dr. Cannon also held faculty positions at Harvard University, Brandeis University, and the University of Massachusetts.
He received a doctorate degree from the University of Georgia.
Lovick Edward Cannon active positions
Companies | Position | Start |
---|---|---|
Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Econet, Inc., Unigen Pharmaceuticals, Inc. operates a research and development company that manufactures and supplies pharmaceutical and biologically active ingredients. The company is based in Lacey, WA. The CEO of the company is Lovick Edward Cannon. | Chief Executive Officer | 17/04/2011 |
NovAb, Inc.
NovAb, Inc. NovAb, Inc. provides healthcare services. The company was incorporated in 2013 and is headquartered in Tucker, GA. | Chief Executive Officer | - |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | Director/Board Member | - |
Former positions of Lovick Edward Cannon
Companies | Position | End |
---|---|---|
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Director/Board Member | - |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | President | - |
University of Massachusetts | Corporate Officer/Principal | - |
Brandeis University | Corporate Officer/Principal | - |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Lovick Edward Cannon
University of Georgia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
AdipoGenix, Inc.
AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA. | Health Technology |
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Health Technology |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
Protein Engineering Corp
Protein Engineering Corp Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Protein Engineering Corp is a company that screens proteins and peptides used in drug discovery. The company is based in Cambridge, MA. Protein Engineering was acquired by Dyax Corp., part of Takeda Pharmaceutical Co., Ltd. from January 25, 2016 on November 15, 1995. | Health Technology |
Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Econet, Inc., Unigen Pharmaceuticals, Inc. operates a research and development company that manufactures and supplies pharmaceutical and biologically active ingredients. The company is based in Lacey, WA. The CEO of the company is Lovick Edward Cannon. | Commercial Services |
Hygeia Sciences, Inc. | |
NovAb, Inc.
NovAb, Inc. NovAb, Inc. provides healthcare services. The company was incorporated in 2013 and is headquartered in Tucker, GA. | |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | Health Technology |
- Stock Market
- Insiders
- Lovick Edward Cannon